North China Pharmaceutical Company.Ltd (SHSE: 600812)
Health Care · Pharmaceuticals · CN
CN¥4.91
-2.58% today · -25.0% 1Y
North China Pharmaceutical Company.Ltd (SHSE: 600812) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.25B and employs 9,972 people.
Over the last twelve months the share price has lost 25.0%, trading between 4.11 and 6.63.
Tweenvest scores North China Pharmaceutical Company.Ltd across four factors: quality 59/100, value 39/100, growth 3/100, dividend 10/100. Its strongest factor is quality.
600812 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.25B
- Revenue (TTM)
- $1.21B
- P/E
- 68.28
- EPS
- 0.07
- Dividend yield
- 0.71%
- Beta (5Y)
- 0.21
- 52-week high
- CN¥6.63
- 52-week low
- CN¥4.11
- Avg volume (3M)
- —
- Shares outstanding
- 1.72B
- Employees
- 9,972
- Next earnings
- —
About North China Pharmaceutical Company.Ltd
North China Pharmaceutical Company Ltd. is a Chinese firm specializing in the chemical pharmaceutical sector. Its extensive product range primarily features anti-infective medications, supplied as active pharmaceutical ingredients (APIs), their intermediates, and final preparations. The company's offerings further encompass biotechnological therapeutics, drugs for cardiovascular conditions, immunomodulators, vitamin-based consumer health products, and specialized pharmaceuticals for agricultural and veterinary applications. Founded in 1953, North China Pharmaceutical Company Ltd. maintains its headquarters in Shijiazhuang, China.
- ISIN
- CNE000000D16
- Founded
- 1992
- Listed since
- Jan 14, 1994
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.